Danaher Corporation (DHR) : Osborne Partners Capital Management reduced its stake in Danaher Corporation by 1.27% during the most recent quarter end. The investment management company now holds a total of 182,737 shares of Danaher Corporation which is valued at $14,872,964 after selling 2,355 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Jul 19, 2016.Danaher Corporation makes up approximately 2.14% of Osborne Partners Capital Management’s portfolio.
Other Hedge Funds, Including , Pennsylvania Trust Co reduced its stake in DHR by selling 624 shares or 16.14% in the most recent quarter. The Hedge Fund company now holds 3,241 shares of DHR which is valued at $263,785. Danaher Corporation makes up approx 0.02% of Pennsylvania Trust Co’s portfolio.Trust Co Of Vermont reduced its stake in DHR by selling 307 shares or 1.13% in the most recent quarter. The Hedge Fund company now holds 26,815 shares of DHR which is valued at $2,182,473. Danaher Corporation makes up approx 0.28% of Trust Co Of Vermont’s portfolio.Curian Capital reduced its stake in DHR by selling 75,416 shares or 63.72% in the most recent quarter. The Hedge Fund company now holds 42,938 shares of DHR which is valued at $3,471,967. Danaher Corporation makes up approx 0.25% of Curian Capital’s portfolio.
Danaher Corporation opened for trading at $81.28 and hit $81.6 on the upside on Wednesday, eventually ending the session at $81.39, with a gain of 0.63% or 0.51 points. The heightened volatility saw the trading volume jump to 23,29,981 shares. Company has a market cap of $56,053 M.
On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.